179 related articles for article (PubMed ID: 35201961)
41. [Experience in treating uveitis of sarcoid etiology].
Chernysheva MV; Chetin VM
Probl Tuberk; 1996; (5):34-5. PubMed ID: 8984488
[No Abstract] [Full Text] [Related]
42. Sarcoidosis-related Uveitis: Clinical Presentation, Disease Course, and Rates of Systemic Disease Progression After Uveitis Diagnosis.
Ma SP; Rogers SL; Hall AJ; Hodgson L; Brennan J; Stawell RJ; Lim LL
Am J Ophthalmol; 2019 Feb; 198():30-36. PubMed ID: 30243930
[TBL] [Abstract][Full Text] [Related]
43. Structural changes of the choroid in sarcoid- and tuberculosis-related granulomatous uveitis.
Mehta H; Sim DA; Keane PA; Zarranz-Ventura J; Gallagher K; Egan CA; Westcott M; Lee RW; Tufail A; Pavesio CE
Eye (Lond); 2015 Aug; 29(8):1060-8. PubMed ID: 26021867
[TBL] [Abstract][Full Text] [Related]
44. Ocular Sarcoidosis.
Sève P; Jamilloux Y; Tilikete C; Gerfaud-Valentin M; Kodjikian L; El Jammal T
Semin Respir Crit Care Med; 2020 Oct; 41(5):673-688. PubMed ID: 32777852
[TBL] [Abstract][Full Text] [Related]
45. [Sarcoid uveitis: Diagnostic and therapeutic update].
Varron L; Abad S; Kodjikian L; Sève P
Rev Med Interne; 2011 Feb; 32(2):86-92. PubMed ID: 20970226
[TBL] [Abstract][Full Text] [Related]
46. Classification Criteria for Sarcoidosis-Associated Uveitis.
Standardization of Uveitis Nomenclature (SUN) Working Group
Am J Ophthalmol; 2021 Aug; 228():220-230. PubMed ID: 33845001
[TBL] [Abstract][Full Text] [Related]
47. Effect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis: Three-Year Results.
Jaffe GJ; Pavesio CE;
Ophthalmology; 2020 Oct; 127(10):1395-1404. PubMed ID: 32624244
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic efficacy of elevated serum angiotensin-converting enzyme and lymphopenia between presumed sarcoid uveitis and presumed tubercular uveitis.
Elango N; Ramdoss J; Udayakumar J; Bavaskar SH; Ranganathan P; Subramaniam Rajesh B; Narayanasamy A; Biswas J
Int Ophthalmol; 2023 Oct; 43(10):3651-3657. PubMed ID: 37468795
[TBL] [Abstract][Full Text] [Related]
49. Uveitis: Study of 109 cases.
Sotomayor Toribio M; Rueda Rueda T; Sánchez Vicente JL; López Herrero F; Cabanás Jiménez M; Mantrana Bermejo ME
Med Clin (Barc); 2023 Aug; 161(3):107-109. PubMed ID: 37248128
[TBL] [Abstract][Full Text] [Related]
50. Multicenter, retrospective, observational study for the Treatment Pattern of systemic corticoSTERoids for relapse of non-infectious uveitis accompanying Vogt-Koyanagi-Harada disease or sarcoidosis.
Namba K; Takase H; Usui Y; Nitta F; Maruyama K; Kusuhara S; Takeuchi M; Azumi A; Yanai R; Kaneko Y; Hasegawa E; Nakai K; Tsuruga H; Morita K; Kaburaki T
Jpn J Ophthalmol; 2022 Mar; 66(2):130-141. PubMed ID: 35044561
[TBL] [Abstract][Full Text] [Related]
51. [Value of alveolar lavage and transbronchial biopsy in the diagnosis of isolated sarcoid uveitis].
Boscher C; De Fenoyl O; Charlot JC; Rochemaure J; Pouliquen Y
J Fr Ophtalmol; 1985; 8(2):159-63. PubMed ID: 2989352
[TBL] [Abstract][Full Text] [Related]
52. Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III.
Suhler EB; Adán A; Brézin AP; Fortin E; Goto H; Jaffe GJ; Kaburaki T; Kramer M; Lim LL; Muccioli C; Nguyen QD; Van Calster J; Cimino L; Kron M; Song AP; Liu J; Pathai S; Camez A; Schlaen A; van Velthoven MEJ; Vitale AT; Zierhut M; Tari S; Dick AD
Ophthalmology; 2018 Jul; 125(7):1075-1087. PubMed ID: 29429764
[TBL] [Abstract][Full Text] [Related]
53. ACQUIRED VITELLIFORM LESIONS THAT RESPOND TO IMMUNE SUPPRESSION IN A PATIENT WITH SARCOIDOSIS.
Heymann HB; Jampol LM
Retin Cases Brief Rep; 2020; 14(2):146-149. PubMed ID: 29068911
[TBL] [Abstract][Full Text] [Related]
54. Injectable Fluocinolone Acetonide Long-Acting Implant for Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Two-Year Results.
Jaffe GJ; Lin P; Keenan RT; Ashton P; Skalak C; Stinnett SS
Ophthalmology; 2016 Sep; 123(9):1940-8. PubMed ID: 27421623
[TBL] [Abstract][Full Text] [Related]
55. Effect of Adalimumab on Visual Functioning in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis in the VISUAL-1 and VISUAL-2 Trials.
Sheppard J; Joshi A; Betts KA; Hudgens S; Tari S; Chen N; Skup M; Dick AD
JAMA Ophthalmol; 2017 Jun; 135(6):511-518. PubMed ID: 28426849
[TBL] [Abstract][Full Text] [Related]
56. Pars plana vitrectomy for cystoid macular edema secondary to sarcoid uveitis.
Kiryu J; Kita M; Tanabe T; Yamashiro K; Miyamoto N; Ieki Y
Ophthalmology; 2001 Jun; 108(6):1140-4. PubMed ID: 11382643
[TBL] [Abstract][Full Text] [Related]
57. [OCULAR SARCOIDOSIS].
Qassoom A; Raviv Sasportas E; Bar A
Harefuah; 2022 Oct; 161(10):628-632. PubMed ID: 36315210
[TBL] [Abstract][Full Text] [Related]
58. Successful Treatment Bilateral Panuveitis with Multiple Systemic Infection in HIV/AIDS Patient: A Case Report.
Susiyanti M; Pambudy IM
Acta Med Indones; 2022 Jan; 54(1):120-123. PubMed ID: 35398833
[TBL] [Abstract][Full Text] [Related]
59. Clinical features of infectious uveitis in a Tunisian population.
Maamouri R; Beldi M; Houman Y; Somai M; Boussema F; Cheour M
Tunis Med; 2023 Feb; 101(2):259-265. PubMed ID: 37682270
[TBL] [Abstract][Full Text] [Related]
60. Clinical Features of Infectious Uveitis in Children Referred to a Hospital-Based Eye Clinic in Italy.
Paroli MP; Restivo L; Ottaviani E; Nardella C; Abicca I; Spadea L; Paroli M
Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36422212
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
